Want to take quizzes and track your credits?
In an independent and assisted living community implementing social isolation and infection prevention, can symptom screening and testing for severe acute respiratory coronavirus 2 identify cases and reduce transmission after exposure to persons with coronavirus disease 2019 (COVID-19)?
In this case series study of 142 residents and staff exposed to persons with COVID-19, 3 asymptomatic infected residents and 2 symptomatic infected staff were identified; 1 week later, 1 additional asymptomatic infected resident was found (staff were not retested); a facility-wide outbreak did not occur.
In independent/assisted living facilities, testing was a better strategy for identifying staff and older adults with COVID-19 than symptom screening. Adherence to social distancing and preventive guidelines may contribute to interruption of COVID-19 transmission.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused epidemic spread of coronavirus disease 2019 (COVID-19) in the Seattle, Washington, metropolitan area, with morbidity and mortality concentrated among residents of skilled nursing facilities. The prevalence of COVID-19 among older adults in independent/assisted living is not understood.
To conduct surveillance for SARS-CoV-2 and describe symptoms of COVID-19 among residents and staff of an independent/assisted living community.
Design, Setting, and Participants
In March 2020, public health surveillance of staff and residents was conducted on site at an assisted and independent living residence for older adults in Seattle, Washington, after exposure to 2 residents who were hospitalized with COVID-19.
Surveillance for SARS-CoV-2 infection in a congregate setting implementing social isolation and infection prevention protocols.
Main Outcomes and Measures
SARS-CoV-2 real-time polymerase chain reaction was performed on nasopharyngeal swabs from residents and staff; a symptom questionnaire was completed assessing fever, cough, and other symptoms for the preceding 14 days. Residents were retested for SARS-CoV-2 7 days after initial screening.
Testing was performed on 80 residents; 62 were women (77%), with mean age of 86 (range, 69-102) years. SARS-CoV-2 was detected in 3 of 80 residents (3.8%); none felt ill, 1 male resident reported resolved cough and 1 loose stool during the preceding 14 days. Virus was also detected in 2 of 62 staff (3.2%); both were symptomatic. One week later, resident SARS-CoV-2 testing was repeated and 1 new infection detected (asymptomatic). All residents remained in isolation and were clinically stable 14 days after the second test.
Conclusions and Relevance
Detection of SARS-CoV-2 in asymptomatic residents highlights challenges in protecting older adults living in congregate settings. In this study, symptom screening failed to identify residents with infections and all 4 residents with SARS-CoV-2 remained asymptomatic after 14 days. Although 1 asymptomatic infection was found on retesting, a widespread facility outbreak was avoided. Compared with skilled nursing settings, in assisted/independent living communities, early surveillance to identify asymptomatic persons among residents and staff, in combination with adherence to recommended preventive strategies, may reduce viral spread.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
Corresponding Author: Alison C. Roxby, MD, MSc, University of Washington, 325 9th Ave, Box 359909, Seattle, WA 98104 (firstname.lastname@example.org).
Accepted for Publication: April 28, 2020.
Published Online: May 21, 2020. doi:10.1001/jamainternmed.2020.2233
Author Contributions: Dr Roxby had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Roxby, Lynch, Dellit, Taylor, Kimball, Arons, Jernigan, Reddy, Lewis, Neme.
Acquisition, analysis, or interpretation of data: Roxby, Greninger, Hatfield, Dellit, James, Taylor, Page, Arons, Munanga, Stone, Cohen, Jerome, Duchin.
Drafting of the manuscript: Roxby, Greninger, Dellit, Arons.
Critical revision of the manuscript for important intellectual content: Roxby, Greninger, Hatfield, Lynch, Dellit, James, Taylor, Page, Kimball, Munanga, Stone, Jernigan, Reddy, Lewis, Cohen, Jerome, Duchin, Neme.
Statistical analysis: Roxby, Greninger, Hatfield.
Obtained funding: Jerome.
Administrative, technical, or material support: Roxby, Greninger, Lynch, Dellit, Taylor, Page, Kimball, Arons, Munanga, Jernigan, Reddy, Lewis, Jerome, Duchin, Neme.
Supervision: Roxby, Greninger, Lynch, Dellit, Jernigan, Lewis, Cohen, Jerome, Neme.
Conflict of Interest Disclosures: Dr Greninger reported personal fees from Abbott Molecular outside the submitted work. No other potential conflicts were reported.
Disclaimer: The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
Additional Contributions: We thank the residents and staff of the facility for participating in this survey.
You currently have no searches saved.